Nabriva Therapeutics
+$0.0037 (+1.94%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBRV and other ETFs, options, and stocks.
About NBRV
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013.
CEO
Theodore R. Schroeder
Employees
73
Headquarters
Dublin, Dublin
Founded
2005
NBRV Key Statistics
Market cap
12.35M
Price-Earnings ratio
—
Dividend yield
—
Average volume
601.22K
High today
$0.20
Low today
$0.1856
Open price
$0.198
Volume
378.41K
52 Week high
$2.32
52 Week low
$0.1803
NBRV Earnings
-$1.11
-$0.74
-$0.37
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours